- NEWS FEATURE
Protein-slaying drugs could be the next blockbuster therapies

Illustration by David Parkins
Access options
Nature 567, 298-300 (2019)
doi: https://doi.org/10.1038/d41586-019-00879-3
References
Krönke, J. et al. Science 343, 301–305 (2014).
Lu, G. et al. Science 343, 305–309 (2014).
Feldman, R. M. R., Correll, C. C., Kaplan, K. B. & Deshaies, R. J. Cell 91, 221–230 (1997).
Sakamoto, K. M. et al. Proc. Natl Acad. Sci. USA 98, 8554–8559 (2001).
Buckley, D. L. et al. Angew. Chem. Int. Ed. 51, 11463–11467 (2012).
Ito, T. et al. Science 327, 1345–1350 (2010).
Bondeson, D. P. et al. Nature Chem. Biol. 11, 611–617 (2015).
Winter, G. E. et al. Science 348, 1376–1381 (2015).
Zengerle, M., Chan, K.-H. & Ciulli, A. ACS Chem. Biol. 10, 1770–1777 (2015).
Buckley, D. L. et al. ACS Chem. Biol. 10, 1831–1837 (2015).
Lu, J. et al. Chem. Biol. 22, 755–763 (2015).
Nabet, B. et al. Nature Chem. Biol. 14, 431–441 (2018).
Deshaies, R. J. Nature Chem. Biol. 11, 634–635 (2015).
Chessum, N. E. A. J. Med. Chem. 61, 918–933 (2018).